Cargando…

Multiple sclerosis and nutrition: back to the future?

Detalles Bibliográficos
Autores principales:	Gold, Ralf, Montalban, Xavier, Haghikia, Aiden
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Therapeutic Perspectives in Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432976/ https://www.ncbi.nlm.nih.gov/pubmed/32863887 http://dx.doi.org/10.1177/1756286420936165

Ejemplares similares

Predictors for Therapy Response to Intrathecal Corticosteroid Therapy in Multiple Sclerosis
por: Vohl, Katja, et al.
Publicado: (2019)

Factors influencing daily treatment choices in multiple sclerosis: practice guidelines, biomarkers and burden of disease
por: Berger, Thomas, et al.
Publicado: (2020)

Review of the treatment options for epilepsy in tuberous sclerosis complex: towards precision medicine
por: Schubert-Bast, Susanne, et al.
Publicado: (2021)

Recovery from COVID-19 in a B-cell-depleted multiple sclerosis patient
por: Wurm, Hannah, et al.
Publicado: (2020)

Propionic acid beneficially modifies osteoporosis biomarkers in patients with multiple sclerosis
por: Duscha, Alexander, et al.
Publicado: (2022)

The NRF2 pathway as potential biomarker for dimethyl fumarate treatment in multiple sclerosis
por: Hammer, Anna, et al.
Publicado: (2018)

Therapeutic Inertia in Multiple Sclerosis Care: A Study of Canadian Neurologists
por: Saposnik, Gustavo, et al.
Publicado: (2018)

Usability of an Educational Intervention to Overcome Therapeutic Inertia in Multiple Sclerosis Care
por: Saposnik, Gustavo, et al.
Publicado: (2018)

Neural Processes of Psychological Stress and Relaxation Predict the Future Evolution of Quality of Life in Multiple Sclerosis
por: Meyer-Arndt, Lil, et al.
Publicado: (2021)

Tremor in Multiple Sclerosis—An Overview and Future Perspectives
por: Makhoul, Karim, et al.
Publicado: (2020)

Combinations of Susceptibility Genes Are Associated with Higher Risk for Multiple Sclerosis and Imply Disease Course Specificity
por: Akkad, Denis A., et al.
Publicado: (2015)

Western lifestyle and immunopathology of multiple sclerosis
por: Matveeva, Olga, et al.
Publicado: (2018)

Multiple Sclerosis Patient-Specific Primary Neurons Differentiated from Urinary Renal Epithelial Cells via Induced Pluripotent Stem Cells
por: Massa, Megan G., et al.
Publicado: (2016)

Multiple Sclerosis as a Syndrome—Implications for Future Management
por: Dwyer, Christopher M., et al.
Publicado: (2020)

Low-dose statin pretreatment improves function and prognosis of recurrent ischemic stroke patients
por: Cui, Chaohua, et al.
Publicado: (2020)

Wernicke–Korsakoff syndrome associated with mtDNA disease
por: Jimoh, Idris Janos, et al.
Publicado: (2020)

Stereo-crossed ablation guided by stereoelectroencephalography for epilepsy: comprehensive coagulations via a network of multi-electrodes
por: Wei, Peng-Hu, et al.
Publicado: (2020)

Intrathecal nusinersen administration in adult spinal muscular atrophy patients with complex spinal anatomy
por: Cordts, Isabell, et al.
Publicado: (2020)

Long-term outcomes of monascin – a novel dual peroxisome proliferator-activated receptor γ/nuclear factor-erythroid 2 related factor-2 agonist in experimental intracerebral hemorrhage
por: Fu, Pengcheng, et al.
Publicado: (2020)

Circulating microRNAs as potential biomarkers and therapeutic targets in spinal muscular atrophy
por: Chen, Tai-Heng
Publicado: (2020)

Human induced pluripotent stem cell models for the study and treatment of Duchenne and Becker muscular dystrophies
por: Piga, Daniela, et al.
Publicado: (2019)

Embolic strokes of undetermined source: theoretical construct or useful clinical tool?
por: Tsivgoulis, Georgios, et al.
Publicado: (2019)

Atorvastatin and growth, rupture of small unruptured intracranial aneurysm: results of a prospective cohort study
por: Wang, Jie, et al.
Publicado: (2021)

Metabolic profiles by (1)H-magnetic resonance spectroscopy in natalizumab-associated post-PML lesions of multiple sclerosis patients who survived progressive multifocal leukoencephalopathy (PML)
por: Schneider, Ruth, et al.
Publicado: (2017)

Effects of repetitive twice-weekly transcranial direct current stimulations on fatigue and fatigability in people with multiple sclerosis
por: Linnhoff, Stefanie, et al.
Publicado: (2023)

Functional Connectivity in Multiple Sclerosis: Recent Findings and Future Directions
por: Tahedl, Marlene, et al.
Publicado: (2018)

Thiamine and diabetes: back to the future?
por: Beltramo, Elena, et al.
Publicado: (2021)

Current Status and Future Opportunities in Modeling Clinical Characteristics of Multiple Sclerosis
por: Liu, Joshua, et al.
Publicado: (2022)

Environmental factors in autoimmune diseases and their role in multiple sclerosis
por: Jörg, Stefanie, et al.
Publicado: (2016)

Peripheral CD19(+) B-cell counts and infusion intervals as a surrogate for long-term B-cell depleting therapy in multiple sclerosis and neuromyelitis optica/neuromyelitis optica spectrum disorders
por: Ellrichmann, Gisa, et al.
Publicado: (2018)

Temporal Dynamics of Diffusion Metrics in Early Multiple Sclerosis and Clinically Isolated Syndrome: A 2-Year Follow-Up Tract-Based Spatial Statistics Study
por: Schneider, Ruth, et al.
Publicado: (2019)

Inflammation in multiple sclerosis
por: Haase, Stefanie, et al.
Publicado: (2021)

Systematic literature review and network meta-analysis in highly active relapsing–remitting multiple sclerosis and rapidly evolving severe multiple sclerosis
por: Huisman, Eline, et al.
Publicado: (2017)

An expert patient program to improve the empowerment and quality of life of people with multiple sclerosis: protocol for a multicenter pre-post intervention study
por: Robles-Sanchez, Miguel Angel, et al.
Publicado: (2023)

Progressive multiple sclerosis: latest therapeutic developments and future directions
por: Faissner, Simon, et al.
Publicado: (2019)

PARP-1 deregulation in multiple sclerosis
por: Meira, Maria, et al.
Publicado: (2019)

Mechanisms Generating Cancer Genome Complexity: Back to the Future
por: Toledo, Franck
Publicado: (2020)

Potential of Sodium MRI as a Biomarker for Neurodegeneration and Neuroinflammation in Multiple Sclerosis
por: Huhn, Konstantin, et al.
Publicado: (2019)

Propionic Acid and Fasudil as Treatment against Rotenone Toxicity in an In Vitro Model of Parkinson’s Disease
por: Ostendorf, Friederike, et al.
Publicado: (2020)

Comorbidity in Multiple Sclerosis
por: Magyari, Melinda, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u61dvihvil3hu052b8gfn16nc6